Where does Angiex's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Angiex's 2 recorded funding rounds.

Premier Alternatives

Angiex

Cambridge, MA · Founded 2015 · Privately Held (backing)

Developer of vascular-targeted biotherapeutics designed for the treatment of solid cancers and other diseases of pathological angiogenesis. Angiex is based in Cambridge, MA and was founded in 2015. Its last reported valuation was $183 million in Aug 2021. It has raised $98.7 million across 2 recorded rounds; the latest was a $22 million early-stage round in Jul 2025.

Last reported valuation

$182.6M

Oct 2026

Priced at

—

Total raised

$98.7M

Last round

Early Stage VC

Jul 2025

Cap table — not yet on record

Angiex's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Angiex with a free account

·The complete investor list: 19 names
·Watch Angiex: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Angiex

Where does Angiex's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Angiex's 2 recorded funding rounds.